Matthew Gumbleton, MD, PhD
![](https://education.binayfoundation.org/sites/default/files/styles/faculty_photo/public/faculty/2024-05/Matthew-Gumbleton-cropped%20headshot.jpg?itok=e-o6pnso)
Matt received his MD and PhD from Upstate Medical University where his thesis project focused on understanding natural killer cell self-tolerance under the mentorship of Bill Kerr. He completed Internal Medicine residency at the University of Utah and Medical Oncology fellowship training at Huntsman Cancer Institute. During this time he also worked as a post-doctoral fellow in Eric Snyder’s lab studying the response of invasive mucinous adenocarcinoma of the lung to targeted therapies. After completing postgraduate training he joined the faculty at Huntsman Cancer Institute specializing in thoracic oncology.
Financial relationships
-
Attribution:SelfType of financial relationship:PatentIneligible company:Alterna TherapeuticsTopic:SHIP1 inhibitors for modulating NK cell self-toleranceDate added:05/09/2024Date updated:05/09/2024
-
Attribution:SelfType of financial relationship:Independent contractorIneligible company:MJH LifesciencesTopic:Discuss highlighted lung cancer abstracts presented at ESMODate added:05/09/2024Date updated:05/09/2024
-
Attribution:SelfType of financial relationship:Independent contractorIneligible company:OMNI Health MediaTopic:Presented interesting clinical casesDate added:05/09/2024Date updated:05/09/2024